Common diagnoses include: Type 2 diabetes Obesity (generally a BMI of 30 or higher) Overweight (BMI of 27 or higher) when combined with a related health condition such as high blood pressure, high cholesterol, sleep apnea, or insulin resistance Some GLP-1 medications approved for diabetes are often prescribed off-label for weight loss
Research applications have expanded to encompass investigations of ghrelin receptor pharmacology, selective signaling pathway activation, and synergistic interactions with GHRH analogs
Brown, E., Cuthbertson, D
doi: 10.1016/j.jconrel.2004.02.010
doi: 10.1093/nar/gkae973 Summary Keywords gut-bone axis, osteoporosis, gut microbiota, immune and endocrine regulation, orthopedic diseases, bone metabolism, bone health Citation Gu C, Du H, Li N, Zhou Y, Li S, Sun Y, Han Y, Xu X and Li X (2025) The gutbone axis in osteoporosis: a multifaceted interaction with implications for bone health
Dieting, or natural weight loss, is linked to a decrease in glucagon-like peptide 1